| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Cardio IQ(R) Advanced Lipid Panel
MessageIncludes
Cardio IQ® Cholesterol, Total; Cardio IQ® HDL Cholesterol; Cardio IQ® Triglycerides; Cardio
IQ® Non-HDL and Calculated
Components; Cardio IQ® Lipoprotein Fractionation, Ion Mobility;
Cardio IQ® Apolipoprotein B; Cardio IQ® Lipoprotein
(a)
If Triglyceride is >400 mg/dL, Cardio IQ® Direct
LDL will be performed at an additional
charge (CPT code(s): 83721).
Test Code
ADVLP
CPT Codes
80061, 83704, 82172, 83695
Includes
Cardio IQ® Cholesterol, Total
Cardio IQ® HDL Cholesterol
Cardio IQ® Triglycerides
Cardio IQ® Non-HDL and Calculated Components
Cardio IQ® Lipoprotein Fractionation, Ion Mobility
Cardio IQ® Apolipoprotein B
Cardio IQ® Lipoprotein (a)
If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721).
If Triglyceride is extremely elevated, >1293 mg/dL, this causes interference in the Cardio IQ® Direct LDL assay, therefore this test cannot be added.
Cardio IQ® HDL Cholesterol
Cardio IQ® Triglycerides
Cardio IQ® Non-HDL and Calculated Components
Cardio IQ® Lipoprotein Fractionation, Ion Mobility
Cardio IQ® Apolipoprotein B
Cardio IQ® Lipoprotein (a)
If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721).
If Triglyceride is extremely elevated, >1293 mg/dL, this causes interference in the Cardio IQ® Direct LDL assay, therefore this test cannot be added.
Preferred Specimen
4 mL serum
Patient Preparation
If a Cholesterol measurement is to be performed along with Triglycerides, but not part of a Lipid Panel, then the patient should be fasting 9-12 hours prior to collection. If the Cholesterol is ordered as part of a Lipid Panel, then a fasting sample is not required.
Minimum Volume
2 mL
Instructions
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been...determined to interfere with assays for... Cholesterol, Uric Acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
Transport Container
Plastic screw-cap vial
Transport Temperature
Refrigerated
Specimen Stability
Room temperature: 24 hours Refrigerated: 7 days Frozen: 15
days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Moderately icteric • Grossly icteric • Grossly
lipemic
Methodology
Enzymatic • Nephelometry • Immunoturbidometric • Ion Mobility • Spectrophotometry (SP)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Mon-Fri a.m.
Report Available
4-7 days
Reference Range
See Laboratory Report
Clinical Significance
The advanced lipid profile provides a more comprehensive assessment of dyslipidemia and cardiovascular risk than standard lipid panel measurements.
Performing Laboratory
Quest Diagnostics Nichols Inst San Juan Capistrano 33608 Ortega Highway San Juan Capistrano, CA 92675
Last Updated: February 17, 2023
